AMD: Oral Pazopanib May Improve Vision, Retinal Thickness

In a small trial, 15 mg oral pazopanib was well-tolerated and linked to improvements in visual acuity, central retinal lesion thickness, and central retinal thickness in some patients with AMD.
Medscape Medical News

Full Story →